The economic profile of peginterferon beta-1a in the treatment of relapsing-remitting multiple sclerosis in Italy
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system with a very high economic impact. Peginterferon beta-1a is the first approved pegylated interferon beta-1a for the treatm...
Multiple Sclerosis and Demyelinating Disorders 2017 2:13
Published on: 21 August 2017